This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Innovator Spotlight: Shinya Ohtsuka and His Anticancer Compound
Introduction: Shinya Ohtsuka is an esteemed inventor based in Osaka, Japan. He is recognized for his contributions to the field of medicinal chemistry, particularly in the development of new anticancer agents. With a focus on innovative solutions, Ohtsuka's work has the potential to make a significant impact in cancer treatment.
Latest Patents: Ohtsuka holds a patent for Di-substituted pyridine derivatives as anticancers. This invention introduces a novel compound that exhibits excellent antitumor effects. The chemical structure is represented by a complex general formula that outlines various components including substituents and functional groups aimed at enhancing the compound's efficacy against tumors.
Career Highlights: Shinya Ohtsuka currently works at Otsuka Pharmaceutical Company, Limited, where he has been involved in cutting-edge research and development of pharmaceutical products. His innovative work in creating effective cancer treatments showcases his dedication to improving patient outcomes.
Collaborations: Throughout his career, Ohtsuka has collaborated with notable coworkers such as Hideki Takasu and Shigekazu Fujita. Their joint efforts have contributed significantly to advancements in pharmaceutical research and the development of promising therapeutic agents.
Conclusion: Shinya Ohtsuka's contributions to the field of medicinal chemistry are marked by his innovative approaches to creating effective cancer treatments. With his work at Otsuka Pharmaceutical Company, Limited, and collaborations with fellow researchers, he continues to play a vital role in the fight against cancer through groundbreaking inventions. His patent on Di-substituted pyridine derivatives stands as a testament to the potential of scientific innovation in transforming healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
